Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-01 Sale | 2026-09-01 5:02 pm | Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDELL Director | 122,071 | $85 | $10,376,035 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:02 pm | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 19,225 | $85 | $1,634,125 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:01 pm | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 12,325 | $85 | $1,047,625 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:01 pm | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 22,225 | $85 | $1,889,125 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:01 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 28,761 | $85 | $2,444,685 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 22,225 | $85 | $1,889,125 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 22,225 | $85 | $1,889,125 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 4:55 pm | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 35,669 | $85 | $3,031,865 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 4:54 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 137,936 | $85 | $11,724,560 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 4:53 pm | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial & Infra. Ofcr. | 79,427 | $85 | $6,751,295 | 0 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 4:52 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 1,402,911 | $85 | $119,247,435 | 0 (Indirect Direct) | View |
| 2026-07-02 Sale | 2026-07-07 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 3,000 | $40 | $120,000 | 19,225 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 5:23 pm | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 6,900 | $35.67 | $246,143 | 6,400 (Direct) | View |
| 2026-04-08 Sale | 2026-04-10 4:33 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 85,163 | $40.1 | $3,415,036 | 244,882 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:13 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 9,911 | $37.37 | $370,411 | 112,018 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:11 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 10,612 | $37.37 | $396,610 | 137,101 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:05 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 21,981 | $37.37 | $821,513 | 1,382,983 (Indirect Direct) | View |
| 2026-03-12 Sale | 2026-03-13 5:46 pm | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 5,000 | $36.15 | $180,761 | 16,300 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 5:44 pm | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 3,000 | $39.67 | $119,010 | 13,300 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 5:43 pm | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer | 6,713 | $39.67 | $266,305 | 78,121 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:11 pm | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $55 | $137,500 | 98,334 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 4:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $45.02 | $225,100 | 135,879 (Direct) | View |
| 2025-11-03 Sale | 2025-11-05 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $42.66 | $213,312 | 140,312 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-20 Option Award | 2026-08-24 4:52 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial & Infra. Ofcr. | 471 | $0 | 79,427 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 4:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 3,969 | $25.19 | 2,274,033 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 4:11 pm | N/A 2029-03-08 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 19,928 | $0 | 2,274,033 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 4:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 4,995 | $20.02 | 2,274,033 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 4:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 6,542 | $15.29 | 2,274,033 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 4:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 4,422 | $22.61 | 2,274,033 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:09 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 15,655 | $0 | 31,955 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:05 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 15,655 | $0 | 38,491 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:04 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 15,655 | $0 | 31,955 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:03 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 15,655 | $0 | 31,955 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:02 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 15,655 | $0 | 31,955 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:01 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDELL Director | 15,655 | $0 | 131,801 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-22 5:00 pm | N/A 2036-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 15,655 | $0 | 22,055 (Direct) | View |
| 2026-05-29 Gift | 2026-06-02 4:04 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 413,300 | $0 | 831,878 (Indirect) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A 2031-09-01 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 78,434 | $0 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 9,624 | $20.02 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 19,336 | $19.64 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 49,474 | $23.98 | 244,882 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:37 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 290,000 | $0 | 1,632,964 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:36 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer | 82,000 | $0 | 134,834 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:34 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 89,000 | $0 | 176,929 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:34 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 77,000 | $0 | 194,713 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:32 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 89,000 | $0 | 89,834 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 5:11 pm | N/A 2035-01-10 | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $0 | 98,334 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 5:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $40.59 | 98,334 (Direct) | View |
| 2025-12-26 Exercise | 2025-12-29 4:36 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 18,000 | $0 | 208,227 (Direct) | View |
| 2025-12-26 Exercise | 2025-12-29 4:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 18,000 | $1.91 | 208,227 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 44,742 | $0 | 1,602,022 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 16,342 | $9.28 | 1,602,022 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 28,400 | $15.29 | 1,602,022 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:28 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 135,879 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:28 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 135,879 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 5:00 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 140,312 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 5:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 140,312 (Direct) | View |